APA (7th ed.) Citation

Warren, A. M., Grossmann, M., Hoermann, R., Zajac, J. D., & Russell, N. (2022). Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): Design and implementation of an open-label randomised trial. Trials, 23(1), 1. https://doi.org/10.1186/s13063-022-06237-5

Chicago Style (17th ed.) Citation

Warren, Annabelle M., Mathis Grossmann, Rudolf Hoermann, Jeffrey D. Zajac, and Nicholas Russell. "Tolvaptan Versus Fluid Restriction in Acutely Hospitalised Patients with Moderate-profound Hyponatraemia (TVFR-HypoNa): Design and Implementation of an Open-label Randomised Trial." Trials 23, no. 1 (2022): 1. https://doi.org/10.1186/s13063-022-06237-5.

MLA (9th ed.) Citation

Warren, Annabelle M., et al. "Tolvaptan Versus Fluid Restriction in Acutely Hospitalised Patients with Moderate-profound Hyponatraemia (TVFR-HypoNa): Design and Implementation of an Open-label Randomised Trial." Trials, vol. 23, no. 1, 2022, p. 1, https://doi.org/10.1186/s13063-022-06237-5.